Alzheimer's disease: The forgetting gene.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

39 citing papers in PubMed, 1 synthesis or guideline pooled it.

1. A systematic review and narrative synthesis of the experiences with caring for older people living with dementia in Sub-Saharan Africa.BMC geriatrics · 2022
   Pooled it
2. Association of type 2 diabetes treatment status with in vivo biomarkers of Alzheimer's disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
   Article
3. Low-Dimensional Nanomaterials in Alzheimer's Disease: Current Applications.Current Alzheimer research · 2026
   Review
4. Effects of West Nile virus on behavioral and cognitive performance, cortical Aβ pathology, viral loads, and immune measures of middle-aged NL-G-F/E3 and NL-G-F/E4 mice.Frontiers in aging neuroscience · 2025
   Article
5. Biomarker-Based Precision Therapy for Alzheimer's Disease: Multidimensional Evidence Leading a New Breakthrough in Personalized Medicine.Journal of clinical medicine · 2024
   Review
6. 2024 Alzheimer's disease facts and figures.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024
   Article
7. Identification of immune cells infiltrating in hippocampus and key genes associated with Alzheimer's disease.BMC medical genomics · 2023
   Article
8. Biomolecules · 2023
   Review
9. Animal models of Alzheimer's disease: Applications, evaluation, and perspectives.Zoological research · 2022
   Review
10. Apolipoprotein E Isoform-Dependent Effects on Human Amyloid Precursor Protein/Aβ-Induced Behavioral Alterations and Cognitive Impairments and Insoluble Cortical Aβ42 Levels.Frontiers in aging neuroscience · 2022
    Article
11. Cognition in Patients With Memory Difficulties and Dementia Relative to APOE e4 Status.Frontiers in psychology · 2021
    Article
12. The Janus-like Association between Proton Pump Inhibitors and Dementia.Current Alzheimer research · 2021
    Article
13. Modeling neurodegeneration inDisease models & mechanisms · 2020
    Review
14. APOE - a genetic marker of comorbidity in subjects with morbid obesity.BMC medical genetics · 2020
    Article
15. Why does the Aβ peptide of Alzheimer share structural similarity with antimicrobial peptides?Communications biology · 2020
    Article
16. Binding between Prion Protein and Aβ Oligomers Contributes to the Pathogenesis of Alzheimer's Disease.Virologica Sinica · 2019
    Review
17. Apolipoprotein E promoter genotypes are not associated with white matter hyperintensity development in high-altitude careers.BMC research notes · 2019
    Article
18. The Genetic Variability ofGenes · 2019
    Review
19. ApoE-associated modulation of neuroprotection from Aβ-mediated neurodegeneration in transgenicDisease models & mechanisms · 2019
    Article
20. Neuronal Apolipoprotein E4 Expression Results in Proteome-Wide Alterations and Compromises Bioenergetic Capacity by Disrupting Mitochondrial Function.Journal of Alzheimer's disease : JAD · 2019
    Article

Corrections and comments

• Commented on by
  Predictive testing and Alzheimer disease.2014

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as